News | March 20, 2026
Clariant boosts US pharmaceutical production with Clear Lake expansion
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
Zydus has developed an innovative formulation of Semaglutide Injection in a prefilled cartridge administered using a reusable patient-friendly pen device
The initial consideration for the transaction is US$ 12 million
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
The product is bioequivalent and therapeutically equivalent to Fresenius Kabi’s reference drug (NDA 212832)
This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin
Desidustat tablets are a novel oral HIF-PHI approved for treating anaemia in non-dialysis adult CKD patients
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
Lilly has long voiced concerns over mass-compounded knockoffs of its tirzepatide medicines, Mounjaro and Zepbound
Subscribe To Our Newsletter & Stay Updated
